The association between platelet transfusion and adverse outcomes after coronary artery bypass surgery

Area of Science:

• Cardiovascular Surgery
• Hematology
• Transfusion Medicine

Background:

• Platelet transfusion is sometimes used during or after coronary artery bypass grafting (CABG).
• Previous studies indicated a potential association between platelet transfusion and adverse outcomes following CABG.
• The current analysis aimed to rigorously investigate this association.

Purpose of the Study:

• To determine if platelet transfusion is associated with adverse events after coronary artery bypass grafting (CABG).
• To evaluate the impact of platelet transfusion on short-term and mid-term outcomes in CABG patients.

Main Methods:

• A retrospective analysis of 6745 patients undergoing CABG between 2006 and 2012.
• Propensity score matching was used to compare 982 patients receiving platelet transfusions with 982 control patients.
• Outcomes assessed included 30-day and 6-month mortality, myocardial infarction, stroke, coronary angiography, and repeat revascularization.

Main Results:

• Platelet transfusion was significantly associated with an increased need for postoperative coronary angiography (aOR 2.34).
• No significant association was found between platelet transfusion and 30-day or 6-month mortality.
• Platelet transfusion did not correlate with increased rates of in-hospital myocardial infarction, stroke, or repeat coronary revascularization.

Conclusions:

• Platelet transfusion during or after CABG is not associated with increased postoperative mortality, myocardial infarction, or stroke.
• The findings suggest that while platelet transfusion does not elevate risks for major adverse cardiovascular events, it may be linked to increased diagnostic procedures like coronary angiography.